{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T10:58:55Z","timestamp":1785409135099,"version":"3.56.0"},"reference-count":72,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2018,5,28]],"date-time":"2018-05-28T00:00:00Z","timestamp":1527465600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["Universal 408676\/2016-7"],"award-info":[{"award-number":["Universal 408676\/2016-7"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007395","name":"Instituto Nacional de Ci\u00eancia e Tecnologia para Excitotoxicidade e Neuroprote\u00e7\u00e3o","doi-asserted-by":"publisher","award":["none"],"award-info":[{"award-number":["none"]}],"id":[{"id":"10.13039\/501100007395","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurotox Res"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1007\/s12640-018-9912-4","type":"journal-article","created":{"date-parts":[[2018,5,28]],"date-time":"2018-05-28T01:29:52Z","timestamp":1527470992000},"page":"808-819","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["The Gender-Biased Effects of Intranasal MPTP Administration on Anhedonic- and Depressive-Like Behaviors in C57BL\/6 Mice: the Role of Neurotrophic Factors"],"prefix":"10.1007","volume":"34","author":[{"given":"Marissa Giovanna","family":"Schamne","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josiel Mileno","family":"Mack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morgana","family":"Moretti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filipe Carvalho","family":"Matheus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger","family":"Walz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence","family":"Lanfumey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui Daniel","family":"Prediger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,5,28]]},"reference":[{"key":"9912_CR1","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/nrneurol.2011.189","volume":"8","author":"D Aarsland","year":"2012","unstructured":"Aarsland D, P\u00e5hlhagen S, Ballard CG, Ehrt U, Svenningsson P (2012) Depression in Parkinson disease\u2014epidemiology, mechanisms and management. Nat Rev Neurol 8:35\u201347. \n                    https:\/\/doi.org\/10.1038\/nrneurol.2011.189","journal-title":"Nat Rev Neurol"},{"key":"9912_CR2","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1007\/s12640-013-9389-0","volume":"24","author":"AS Aguiar","year":"2013","unstructured":"Aguiar AS, Trist\u00e3o FSM, Amar M, Chevarin C, Lanfumey L, Mongeau R, Corti O, Prediger RD, Raisman-Vozari R (2013) Parkin-knockout mice did not display increased vulnerability to intranasal administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). Neurotox Res 24:280\u2013287. \n                    https:\/\/doi.org\/10.1007\/s12640-013-9389-0","journal-title":"Neurotox Res"},{"key":"9912_CR3","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1016\/j.pbb.2010.03.009","volume":"95","author":"E Antzoulatos","year":"2010","unstructured":"Antzoulatos E, Jakowec MW, Petzinger GM, Wood RI (2010) Sex differences in motor behavior in the MPTP mouse model of Parkinson\u2019s disease. Pharmacol Biochem Behav 95:466\u2013472. \n                    https:\/\/doi.org\/10.1016\/j.pbb.2010.03.009","journal-title":"Pharmacol Biochem Behav"},{"key":"9912_CR4","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1038\/mp.2011.107","volume":"17","author":"F Boulle","year":"2012","unstructured":"Boulle F, van den Hove DL, Jakob SB et al (2012) Epigenetic regulation of the BDNF gene: implications for psychiatric disorders. Mol Psychiatry 17:584\u2013596. \n                    https:\/\/doi.org\/10.1038\/mp.2011.107","journal-title":"Mol Psychiatry"},{"key":"9912_CR5","doi-asserted-by":"publisher","DOI":"10.1038\/tp.2014.125","volume":"4","author":"F Boulle","year":"2014","unstructured":"Boulle F, Massart R, Stragier E, Pa\u00efzanis E, Zaidan L, Marday S, Gabriel C, Mocaer E, Mongeau R, Lanfumey L (2014) Hippocampal and behavioral dysfunctions in a mouse model of environmental stress: normalization by agomelatine. Transl Psychiatry 4:e485. \n                    https:\/\/doi.org\/10.1038\/tp.2014.125","journal-title":"Transl Psychiatry"},{"key":"9912_CR6","doi-asserted-by":"publisher","first-page":"e35538","DOI":"10.1371\/journal.pone.0035538","volume":"7","author":"SL Byers","year":"2012","unstructured":"Byers SL, Wiles MV, Dunn SL, Taft RA (2012) Mouse estrous cycle identification tool and images. PLoS One 7:e35538. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0035538","journal-title":"PLoS One"},{"key":"9912_CR7","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/j.phrs.2012.01.003","volume":"65","author":"A Carpentieri","year":"2012","unstructured":"Carpentieri A, D\u00edaz De Barboza G, Areco V et al (2012) New perspectives in melatonin uses. Pharmacol Res 65:437\u2013444. \n                    https:\/\/doi.org\/10.1016\/j.phrs.2012.01.003","journal-title":"Pharmacol Res"},{"key":"9912_CR8","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.bbr.2012.01.016","volume":"229","author":"AA Castro","year":"2012","unstructured":"Castro AA, Ghisoni K, Latini A, Quevedo J, Tasca CI, Prediger RDS (2012) Lithium and valproate prevent olfactory discrimination and short-term memory impairments in the intranasal 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) rat model of Parkinson\u2019s disease. Behav Brain Res 229:208\u2013215. \n                    https:\/\/doi.org\/10.1016\/j.bbr.2012.01.016","journal-title":"Behav Brain Res"},{"key":"9912_CR9","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.brainres.2013.03.029","volume":"1513","author":"AA Castro","year":"2013","unstructured":"Castro AA, Wiemes BP, Matheus FC, Lapa FR, Viola GG, Santos AR, Tasca CI, Prediger RD (2013) Atorvastatin improves cognitive, emotional and motor impairments induced by intranasal 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) administration in rats, an experimental model of Parkinson\u2019s disease. Brain Res 1513:103\u2013116. \n                    https:\/\/doi.org\/10.1016\/j.brainres.2013.03.029","journal-title":"Brain Res"},{"key":"9912_CR10","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1016\/j.jpsychires.2013.04.008","volume":"47","author":"A Clark-Raymond","year":"2013","unstructured":"Clark-Raymond A, Halaris A (2013) VEGF and depression: a comprehensive assessment of clinical data. J Psychiatr Res 47:1080\u20131087. \n                    https:\/\/doi.org\/10.1016\/j.jpsychires.2013.04.008","journal-title":"J Psychiatr Res"},{"key":"9912_CR11","doi-asserted-by":"publisher","DOI":"10.3389\/fnana.2015.00010","volume":"9","author":"X d\u2019Anglemont de Tassigny","year":"2015","unstructured":"d\u2019Anglemont de Tassigny X, Pascual A, L\u00f3pez-Barneo J (2015) GDNF-based therapies, GDNF-producing interneurons, and trophic support of the dopaminergic nigrostriatal pathway. Implications for Parkinson\u2019s disease. Front Neuroanat 9:10. \n                    https:\/\/doi.org\/10.3389\/fnana.2015.00010","journal-title":"Front Neuroanat"},{"key":"9912_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2016\/6503162","volume":"2016","author":"ER Kloet de","year":"2016","unstructured":"de Kloet ER, Molendijk ML (2016) Coping with the forced swim stressor: towards understanding an adaptive mechanism. Neural Plast 2016:1\u201313. \n                    https:\/\/doi.org\/10.1155\/2016\/6503162","journal-title":"Neural Plast"},{"key":"9912_CR13","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/j.psyneuen.2008.10.021","volume":"34","author":"AJ Devall","year":"2009","unstructured":"Devall AJ, Liu ZW, Lovick TA (2009) Hyperalgesia in the setting of anxiety: sex differences and effects of the oestrous cycle in Wistar rats. Psychoneuroendocrinology 34:587\u2013596. \n                    https:\/\/doi.org\/10.1016\/j.psyneuen.2008.10.021","journal-title":"Psychoneuroendocrinology"},{"key":"9912_CR14","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.bbr.2011.07.038","volume":"225","author":"AJ Devall","year":"2011","unstructured":"Devall AJ, Santos JM, Lovick TA (2011) Estrous cycle stage influences on neuronal responsiveness to repeated anxiogenic stress in female rats. Behav Brain Res 225:334\u2013340. \n                    https:\/\/doi.org\/10.1016\/j.bbr.2011.07.038","journal-title":"Behav Brain Res"},{"key":"9912_CR15","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.1007\/s10072-016-2681-z","volume":"37","author":"AP Diaz","year":"2016","unstructured":"Diaz AP, Freitas FC, de Oliveira Thais ME, da Silva Areas FZ, Schwarzbold ML, Debona R, Nunes JC, Guarnieri R, Martinez-Ramirez D, Prediger RD, Wagle Shukla A, Linhares MN, Walz R (2016) Variables associated with physical health-related quality of life in Parkinson\u2019s disease patients presenting for deep brain stimulation. Neurol Sci 37:1831\u20131837. \n                    https:\/\/doi.org\/10.1007\/s10072-016-2681-z","journal-title":"Neurol Sci"},{"key":"9912_CR16","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.parkreldis.2017.02.017","volume":"38","author":"ME Domell\u00f6f","year":"2017","unstructured":"Domell\u00f6f ME, Lundin K-F, Edstr\u00f6m M, Forsgren L (2017) Olfactory dysfunction and dementia in newly diagnosed patients with Parkinson\u2019s disease. Parkinsonism Relat Disord 38:41\u201347. \n                    https:\/\/doi.org\/10.1016\/j.parkreldis.2017.02.017","journal-title":"Parkinsonism Relat Disord"},{"issue":"1","key":"9912_CR17","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1002\/ana.21327","volume":"63","author":"Richard L. Doty","year":"2008","unstructured":"Doty RL (2008) The olfactory vector hypothesis of neurodegenerative disease: is it viable? Ann Neurol. 63(1):7\u201315. \n                    https:\/\/doi.org\/10.1002\/ana.21327","journal-title":"Annals of Neurology"},{"key":"9912_CR18","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1007\/PL00007725","volume":"244","author":"B Dubois","year":"1997","unstructured":"Dubois B, Pillon B (1997) Cognitive deficits in Parkinson\u2019s disease. J Neurol 244:2\u20138","journal-title":"J Neurol"},{"key":"9912_CR19","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.neuropharm.2011.08.044","volume":"62","author":"RS Duman","year":"2012","unstructured":"Duman RS, Li N, Liu RJ, Duric V, Aghajanian G (2012) Signaling pathways underlying the rapid antidepressant actions of ketamine. Neuropharmacology 62:35\u201341. \n                    https:\/\/doi.org\/10.1016\/j.neuropharm.2011.08.044","journal-title":"Neuropharmacology"},{"key":"9912_CR20","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/S0895-4356(01)00425-5","volume":"55","author":"A Elbaz","year":"2002","unstructured":"Elbaz A, Bower JH, Maraganore DM, McDonnell SK, Peterson BJ, Ahlskog JE, Schaid DJ, Rocca WA (2002) Risk tables for parkinsonism and Parkinson\u2019s disease. J Clin Epidemiol 55:25\u201331","journal-title":"J Clin Epidemiol"},{"key":"9912_CR21","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.neuroscience.2016.05.024","volume":"329","author":"A Eskelund","year":"2016","unstructured":"Eskelund A, Budac DP, Sanchez C, Elfving B, Wegener G (2016) Female flinders sensitive line rats show estrous cycle-independent depression-like behavior and altered tryptophan metabolism. Neuroscience 329:337\u2013348. \n                    https:\/\/doi.org\/10.1016\/j.neuroscience.2016.05.024","journal-title":"Neuroscience"},{"key":"9912_CR22","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1095\/biolreprod31.3.446","volume":"31","author":"LS Felicio","year":"1984","unstructured":"Felicio LS, Nelson JF, Finch CE (1984) Longitudinal studies of estrous cyclicity in aging C57BL\/6J mice: II. Cessation of cyclicity and the duration of persistent vaginal cornification. Biol Reprod 31:446\u2013453","journal-title":"Biol Reprod"},{"issue":"1 Neuroprotecti","key":"9912_CR23","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1111\/j.1749-6632.1997.tb48427.x","volume":"825","author":"TIM E. FREYALDENHOVEN","year":"1997","unstructured":"Freyaldenhoven TE, Ali SF(1997) Role of heat shock proteins in MPTP-induced neurotoxicity. Ann N Y Acad Sci. 15(825):167\u201378","journal-title":"Annals of the New York Academy of Sciences"},{"key":"9912_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/ane.12796","volume":"136","author":"D Georgiev","year":"2017","unstructured":"Georgiev D, Hamberg K, Hariz M, Forsgren L, Hariz GM (2017) Gender differences in Parkinson\u2019s disease: a clinical perspective. Acta Neurol Scand 136:1\u201315. \n                    https:\/\/doi.org\/10.1111\/ane.12796","journal-title":"Acta Neurol Scand"},{"key":"9912_CR25","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1002\/mds.22379","volume":"24","author":"CG Goetz","year":"2009","unstructured":"Goetz CG, Stebbins GT, Wolff D, DeLeeuw W, Bronte-Stewart H, Elble R, Hallett M, Nutt J, Ramig L, Sanger T, Wu AD, Kraus PH, Blasucci LM, Shamim EA, Sethi KD, Spielman J, Kubota K, Grove AS, Dishman E, Taylor CB (2009) Testing objective measures of motor impairment in early Parkinson\u2019s disease: feasibility study of an at-home testing device. Mov Disord 24:551\u2013556. \n                    https:\/\/doi.org\/10.1002\/mds.22379","journal-title":"Mov Disord"},{"key":"9912_CR26","doi-asserted-by":"publisher","first-page":"2459","DOI":"10.1038\/npp.2009.68","volume":"34","author":"J Greene","year":"2009","unstructured":"Greene J, Banasr M, Lee B, Warner-Schmidt J, Duman RS (2009) Vascular endothelial growth factor signaling is required for the behavioral actions of antidepressant treatment: pharmacological and cellular characterization. Neuropsychopharmacology 34:2459\u20132468. \n                    https:\/\/doi.org\/10.1038\/npp.2009.68","journal-title":"Neuropsychopharmacology"},{"key":"9912_CR27","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/S0165-6147(97)01050-X","volume":"18","author":"JJ Hagan","year":"1997","unstructured":"Hagan JJ, Middlemiss DN, Sharpe PC, Poste GH (1997) Parkinson\u2019s disease: prospects for improved drug therapy. Trends Pharmacol Sci 18:156\u2013163","journal-title":"Trends Pharmacol Sci"},{"key":"9912_CR28","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1586\/14737175.8.7.1125","volume":"8","author":"M Hong","year":"2008","unstructured":"Hong M, Mukhida K, Mendez I (2008) GDNF therapy for Parkinson\u2019s disease. Expert Rev Neurother 8:1125\u20131139. \n                    https:\/\/doi.org\/10.1586\/14737175.8.7.1125","journal-title":"Expert Rev Neurother"},{"key":"9912_CR29","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1006\/exnr.2000.7483","volume":"166","author":"DW Howells","year":"2000","unstructured":"Howells DW, Porritt MJ, Wong JYF, Batchelor PE, Kalnins R, Hughes AJ, Donnan GA (2000) Reduced BDNF mRNA expression in the Parkinson\u2019s disease substantia nigra. Exp Neurol 166:127\u2013135. \n                    https:\/\/doi.org\/10.1006\/exnr.2000.7483","journal-title":"Exp Neurol"},{"key":"9912_CR30","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1007\/978-1-61779-415-5_34","volume-title":"Methods in Molecular Biology","author":"Aymen I. Idris","year":"2011","unstructured":"Idris AI (2012) Ovariectomy\/orchidectomy in rodents. Methods Mol Biol (816)545\u2013551. \n                    https:\/\/doi.org\/10.1007\/978-1-61779-415-5_34"},{"key":"9912_CR31","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/0197-0186(94)00122-B","volume":"26","author":"Y Itano","year":"1995","unstructured":"Itano Y, Kitamura Y, Nomura Y (1995) Biphasic effects of MPP+, a possible parkinsonism inducer, on dopamine content and tyrosine hydroxylase mRNA expression in PC12 cells. Neurochem Int 26:165\u2013171","journal-title":"Neurochem Int"},{"key":"9912_CR32","doi-asserted-by":"publisher","first-page":"3521","DOI":"10.1073\/pnas.84.10.3521","volume":"84","author":"RN Kalaria","year":"1987","unstructured":"Kalaria RN, Mitchell MJ, Harik SI (1987) Correlation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity with blood-brain barrier monoamine oxidase activity. Proc Natl Acad Sci U S A 84:3521\u20133525","journal-title":"Proc Natl Acad Sci U S A"},{"key":"9912_CR33","doi-asserted-by":"publisher","unstructured":"Klemann CJHM, Martens GJM, Sharma M, Martens MB, Isacson O, Gasser T, Visser JE, Poelmans G (2017) Integrated molecular landscape of Parkinson\u2019s disease. NPJ Parkinsons Dis 3:14. \n                    https:\/\/doi.org\/10.1038\/s41531-017-0015-3","DOI":"10.1038\/s41531-017-0015-3"},{"key":"9912_CR34","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1038\/nature07455","volume":"455","author":"V Krishnan","year":"2008","unstructured":"Krishnan V, Nestler EJ (2008) The molecular neurobiology of depression. Nature 455:894\u2013902. \n                    https:\/\/doi.org\/10.1038\/nature07455","journal-title":"Nature"},{"key":"9912_CR35","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.neulet.2014.12.030","volume":"589","author":"R Kumari","year":"2015","unstructured":"Kumari R, Kumar JBS, Luthra PM (2015) Post-lesion administration of 7-NI attenuated motor and non-motor deficits in 6-OHDA induced bilaterally lesioned female rat model of Parkinson\u2019s disease. Neurosci Lett 589:191\u2013195. \n                    https:\/\/doi.org\/10.1016\/j.neulet.2014.12.030","journal-title":"Neurosci Lett"},{"key":"9912_CR36","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.bbr.2011.03.022","volume":"222","author":"BJ Martynhak","year":"2011","unstructured":"Martynhak BJ, Correia D, Morais LH, Araujo P, Andersen ML, Lima MMS, Louzada FM, Andreatini R (2011) Neonatal exposure to constant light prevents anhedonia-like behavior induced by constant light exposure in adulthood. Behav Brain Res 222:10\u201314. \n                    https:\/\/doi.org\/10.1016\/j.bbr.2011.03.022","journal-title":"Behav Brain Res"},{"issue":"Suppl 4","key":"9912_CR37","first-page":"827","volume":"24","author":"J Massano","year":"2011","unstructured":"Massano J (2011) Parkinson\u2019s disease: a clinical update. Acta M\u00e9dica Port 24(Suppl 4):827\u2013834","journal-title":"Acta M\u00e9dica Port"},{"key":"9912_CR38","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.bbr.2012.08.017","volume":"235","author":"FC Matheus","year":"2012","unstructured":"Matheus FC, Aguiar AS, Castro AA et al (2012) Neuroprotective effects of agmatine in mice infused with a single intranasal administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). Behav Brain Res 235:263\u2013272. \n                    https:\/\/doi.org\/10.1016\/j.bbr.2012.08.017","journal-title":"Behav Brain Res"},{"issue":"Suppl 1","key":"9912_CR39","doi-asserted-by":"publisher","first-page":"S117","DOI":"10.1002\/mds.22788","volume":"25","author":"M Menza","year":"2010","unstructured":"Menza M, Dobkin RD, Marin H, Bienfait K (2010) Sleep disturbances in Parkinson\u2019s disease. Mov Disord 25(Suppl 1):S117\u2013SS22. \n                    https:\/\/doi.org\/10.1002\/mds.22788","journal-title":"Mov Disord"},{"key":"9912_CR40","doi-asserted-by":"publisher","first-page":"2695","DOI":"10.1002\/mds.23388","volume":"25","author":"IN Miller","year":"2010","unstructured":"Miller IN, Cronin-Golomb A (2010) Gender differences in Parkinson\u2019s disease: clinical characteristics and cognition. Mov Disord 25:2695\u20132703. \n                    https:\/\/doi.org\/10.1002\/mds.23388","journal-title":"Mov Disord"},{"key":"9912_CR41","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1007\/s00702-010-0464-x","volume":"117","author":"ELG Moreira","year":"2010","unstructured":"Moreira ELG, Rial D, Aguiar AS, Figueiredo CP, Siqueira JM, DalB\u00f3 S, Horst H, de Oliveira J, Mancini G, dos Santos TS, Villarinho JG, Pinheiro FV, Marino-Neto J, Ferreira J, de Bem AF, Latini A, Pizzolatti MG, Ribeiro-do-Valle RM, Prediger RDS (2010) Proanthocyanidin-rich fraction from Croton celtidifolius Baill confers neuroprotection in the intranasal 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine rat model of Parkinson\u2019s disease. J Neural Transm 117:1337\u20131351. \n                    https:\/\/doi.org\/10.1007\/s00702-010-0464-x","journal-title":"J Neural Transm"},{"key":"9912_CR42","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.jpsychires.2011.11.009","volume":"46","author":"M Moretti","year":"2012","unstructured":"Moretti M, Colla A, de Oliveira Balen G, dos Santos DB, Budni J, de Freitas AE, Farina M, Severo Rodrigues AL (2012) Ascorbic acid treatment, similarly to fluoxetine, reverses depressive-like behavior and brain oxidative damage induced by chronic unpredictable stress. J Psychiatr Res 46:331\u2013340. \n                    https:\/\/doi.org\/10.1016\/j.jpsychires.2011.11.009","journal-title":"J Psychiatr Res"},{"key":"9912_CR43","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1007\/s12640-015-9540-1","volume":"28","author":"M Moretti","year":"2015","unstructured":"Moretti M, Neis VB, Matheus FC, Cunha MP, Rosa PB, Ribeiro CM, Rodrigues ALS, Prediger RD (2015) Effects of agmatine on depressive-like behavior induced by intracerebroventricular administration of 1-methyl-4-phenylpyridinium (MPP+). Neurotox Res 28:222\u2013231. \n                    https:\/\/doi.org\/10.1007\/s12640-015-9540-1","journal-title":"Neurotox Res"},{"key":"9912_CR44","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1034\/j.1600-0447.2002.02229.x","volume":"106","author":"FM Nilsson","year":"2002","unstructured":"Nilsson FM, Kessing LV, S\u00f8rensen TM et al (2002) Major depressive disorder in Parkinson\u2019s disease: a register-based study. Acta Psychiatr Scand 106:202\u2013211","journal-title":"Acta Psychiatr Scand"},{"key":"9912_CR45","doi-asserted-by":"publisher","first-page":"S7","DOI":"10.1212\/WNL.55.1.7","volume":"55","author":"JA Obeso","year":"2000","unstructured":"Obeso JA, Rodriguez-Oroz MC, Rodriguez M, Macias R, Alvarez L, Guridi J, Vitek J, DeLong M (2000) Pathophysiologic basis of surgery for Parkinson\u2019s disease. Neurology 55:S7\u2013S12","journal-title":"Neurology"},{"key":"9912_CR46","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.mce.2009.07.011","volume":"311","author":"M Ookubo","year":"2009","unstructured":"Ookubo M, Yokoyama H, Kato H, Araki T (2009) Gender differences on MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) neurotoxicity in C57BL\/6 mice. Mol Cell Endocrinol 311:62\u201368. \n                    https:\/\/doi.org\/10.1016\/j.mce.2009.07.011","journal-title":"Mol Cell Endocrinol"},{"key":"9912_CR47","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1016\/j.jpsychires.2008.01.010","volume":"42","author":"K Otsuki","year":"2008","unstructured":"Otsuki K, Uchida S, Watanuki T, Wakabayashi Y, Fujimoto M, Matsubara T, Funato H, Watanabe Y (2008) Altered expression of neurotrophic factors in patients with major depression. J Psychiatr Res 42:1145\u20131153. \n                    https:\/\/doi.org\/10.1016\/j.jpsychires.2008.01.010","journal-title":"J Psychiatr Res"},{"key":"9912_CR48","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1007\/978-3-211-33081-4_16","volume":"97","author":"NK Patel","year":"2007","unstructured":"Patel NK, Gill SS (2007) GDNF delivery for Parkinson\u2019s disease. Acta Neurochir Suppl 97:135\u2013154","journal-title":"Acta Neurochir Suppl"},{"key":"9912_CR49","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1038\/266730a0","volume":"266","author":"RD Porsolt","year":"1977","unstructured":"Porsolt RD, Le Pichon M, Jalfre M (1977) Depression: a new animal model sensitive to antidepressant treatments. Nature 266:730\u2013732","journal-title":"Nature"},{"key":"9912_CR50","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/0014-2999(78)90118-8","volume":"47","author":"RD Porsolt","year":"1978","unstructured":"Porsolt RD, Anton G, Blavet N, Jalfre M (1978) Behavioural despair in rats: a new model sensitive to antidepressant treatments. Eur J Pharmacol 47:379\u2013391. \n                    https:\/\/doi.org\/10.1016\/0014-2999(78)90118-8","journal-title":"Eur J Pharmacol"},{"issue":"Suppl 1","key":"9912_CR51","doi-asserted-by":"publisher","first-page":"S205","DOI":"10.3233\/JAD-2010-091459","volume":"20","author":"RDS Prediger","year":"2010","unstructured":"Prediger RDS (2010) Effects of caffeine in Parkinson\u2019s disease: from neuroprotection to the management of motor and non-motor symptoms. J Alzheimers Dis 20(Suppl 1):S205\u2013S220. \n                    https:\/\/doi.org\/10.3233\/JAD-2010-091459","journal-title":"J Alzheimers Dis"},{"issue":"2","key":"9912_CR52","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1007\/s12640-009-9087-0","volume":"17","author":"Rui D. S. Prediger","year":"2009","unstructured":"Prediger RD, Aguiar AS Jr, Rojas-Mayorquin AE et al (2010) Single intranasal administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in C57BL\/6 mice models early preclinical phase of Parkinson's disease. Neurotox Res. 17(2):114\u201329. \n                    https:\/\/doi.org\/10.1007\/s12640-009-9087-0","journal-title":"Neurotoxicity Research"},{"key":"9912_CR53","doi-asserted-by":"publisher","first-page":"489","DOI":"10.2174\/138161211795164095","volume":"17","author":"RDS Prediger","year":"2011","unstructured":"Prediger RDS, Aguiar ASJ, Moreira ELG et al (2011) The intranasal administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): a new rodent model to test palliative and neuroprotective agents for Parkinson\u2019s disease. Curr Pharm Des 17:489\u2013507. \n                    https:\/\/doi.org\/10.2174\/138161211795164095","journal-title":"Curr Pharm Des"},{"key":"9912_CR54","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1007\/s12640-011-9281-8","volume":"21","author":"RDS Prediger","year":"2012","unstructured":"Prediger RDS, Aguiar AS, Matheus FC, Walz R, Antoury L, Raisman-Vozari R, Doty RL (2012a) Intranasal administration of neurotoxicants in animals: support for the olfactory vector hypothesis of Parkinson\u2019s disease. Neurotox Res 21:90\u2013116. \n                    https:\/\/doi.org\/10.1007\/s12640-011-9281-8","journal-title":"Neurotox Res"},{"key":"9912_CR55","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.neuropharm.2011.08.039","volume":"62","author":"RDS Prediger","year":"2012","unstructured":"Prediger RDS, Matheus FC, Schwarzbold ML, Lima MMS, Vital MABF (2012b) Anxiety in Parkinson\u2019s disease: a critical review of experimental and clinical studies. Neuropharmacology 62:115\u2013124. \n                    https:\/\/doi.org\/10.1016\/j.neuropharm.2011.08.039","journal-title":"Neuropharmacology"},{"key":"9912_CR56","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1002\/mds.21803","volume":"23","author":"JSAM Reijnders","year":"2008","unstructured":"Reijnders JSAM, Ehrt U, Weber WEJ, Aarsland D, Leentjens AFG (2008) A systematic review of prevalence studies of depression in Parkinson\u2019s disease. Mov Disord 23:183\u2013189. \n                    https:\/\/doi.org\/10.1002\/mds.21803\n                    \n                   quiz 313","journal-title":"Mov Disord"},{"key":"9912_CR57","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1097\/JCP.0b013e3181fc2ec7","volume":"30","author":"V Ricci","year":"2010","unstructured":"Ricci V, Pomponi M, Martinotti G, Bentivoglio A, Loria G, Bernardini S, Caltagirone C, Bria P, Angelucci F (2010) Antidepressant treatment restores brain-derived neurotrophic factor serum levels and ameliorates motor function in Parkinson disease patients. J Clin Psychopharmacol 30:751\u2013753. \n                    https:\/\/doi.org\/10.1097\/JCP.0b013e3181fc2ec7","journal-title":"J Clin Psychopharmacol"},{"key":"9912_CR58","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1177\/0891988709351833","volume":"23","author":"O Riedel","year":"2010","unstructured":"Riedel O, Heuser I, Klotsche J, Dodel R, Wittchen HU, GEPAD Study Group (2010a) Occurrence risk and structure of depression in Parkinson disease with and without dementia: results from the GEPAD study. J Geriatr Psychiatry Neurol 23:27\u201334. \n                    https:\/\/doi.org\/10.1177\/0891988709351833","journal-title":"J Geriatr Psychiatry Neurol"},{"key":"9912_CR59","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1007\/s00415-010-5465-z","volume":"257","author":"O Riedel","year":"2010","unstructured":"Riedel O, Klotsche J, Spottke A, Deuschl G, F\u00f6rstl H, Henn F, Heuser I, Oertel W, Reichmann H, Riederer P, Trenkwalder C, Dodel R, Wittchen HU (2010b) Frequency of dementia, depression, and other neuropsychiatric symptoms in 1,449 outpatients with Parkinson\u2019s disease. J Neurol 257:1073\u20131082. \n                    https:\/\/doi.org\/10.1007\/s00415-010-5465-z","journal-title":"J Neurol"},{"key":"9912_CR60","unstructured":"Sampaio TB, Roversi K, Schamne MG, et al (2017) Clinical pharmacology and translational medicine review article the relevance of intranasal route in Parkinson\u2019s disease: from physiopathological alterations to administration of neurotoxins. 1:20\u201337"},{"key":"9912_CR61","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1016\/j.pnpbp.2010.06.004","volume":"34","author":"RM Santiago","year":"2010","unstructured":"Santiago RM, Barbieiro J, Lima MMS, Dombrowski PA, Andreatini R, Vital MABF (2010) Depressive-like behaviors alterations induced by intranigral MPTP, 6-OHDA, LPS and rotenone models of Parkinson\u2019s disease are predominantly associated with serotonin and dopamine. Prog Neuro-Psychopharmacol Biol Psychiatry 34:1104\u20131114. \n                    https:\/\/doi.org\/10.1016\/j.pnpbp.2010.06.004","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"key":"9912_CR62","doi-asserted-by":"publisher","first-page":"87","DOI":"10.3233\/JPD-2012-12076","volume":"2","author":"N Schintu","year":"2012","unstructured":"Schintu N, Zhang X, Svenningsson P (2012) Studies of depression-related states in animal models of parkinsonism. J Parkinsons Dis 2:87\u2013106. \n                    https:\/\/doi.org\/10.3233\/JPD-2012-12076","journal-title":"J Parkinsons Dis"},{"key":"9912_CR63","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1007\/s00415-004-0483-3","volume":"251","author":"A Schrag","year":"2004","unstructured":"Schrag A (2004) Psychiatric aspects of Parkinson\u2019s disease\u2014an update. J Neurol 251:795\u2013804. \n                    https:\/\/doi.org\/10.1007\/s00415-004-0483-3","journal-title":"J Neurol"},{"key":"9912_CR64","doi-asserted-by":"publisher","first-page":"11352","DOI":"10.1073\/pnas.0710858105","volume":"105","author":"E Segi-Nishida","year":"2008","unstructured":"Segi-Nishida E, Warner-Schmidt JL, Duman RS (2008) Electroconvulsive seizure and VEGF increase the proliferation of neural stem-like cells in rat hippocampus. Proc Natl Acad Sci U S A 105:11352\u201311357. \n                    https:\/\/doi.org\/10.1073\/pnas.0710858105","journal-title":"Proc Natl Acad Sci U S A"},{"key":"9912_CR65","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.jad.2016.02.067","volume":"197","author":"AN Sharma","year":"2016","unstructured":"Sharma AN, da Costa e Silva BFB, Soares JC, Soares JC, Carvalho AF, Quevedo J (2016) Role of trophic factors GDNF, IGF-1 and VEGF in major depressive disorder: a comprehensive review of human studies. J Affect Disord 197:9\u201320. \n                    https:\/\/doi.org\/10.1016\/j.jad.2016.02.067","journal-title":"J Affect Disord"},{"key":"9912_CR66","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1007\/BF00428203","volume":"85","author":"L Steru","year":"1985","unstructured":"Steru L, Chermat R, Thierry B, Simon P (1985) The tail suspension test: a new method for screening antidepressants in mice. Psychopharmacology 85:367\u2013370","journal-title":"Psychopharmacology"},{"key":"9912_CR67","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1111\/cns.12544","volume":"22","author":"JC Szczepanik","year":"2016","unstructured":"Szczepanik JC, de Oliveira PA, de Oliveira J, Mack JM, Engel DF, Rial D, Moreira ELG, de Bem AF, Prediger RD (2016) Caffeine mitigates the locomotor hyperactivity in middle-aged low-density lipoprotein receptor (LDLr)-knockout mice. CNS Neurosci Ther 22:420\u2013422. \n                    https:\/\/doi.org\/10.1111\/cns.12544","journal-title":"CNS Neurosci Ther"},{"key":"9912_CR68","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1016\/j.neuroscience.2008.08.035","volume":"156","author":"MT Tadaiesky","year":"2008","unstructured":"Tadaiesky MT, Dombrowski PA, Figueiredo CP, Cargnin-Ferreira E, da Cunha C, Takahashi RN (2008) Emotional, cognitive and neurochemical alterations in a premotor stage model of Parkinson\u2019s disease. Neuroscience 156:830\u2013840. \n                    https:\/\/doi.org\/10.1016\/j.neuroscience.2008.08.035","journal-title":"Neuroscience"},{"issue":"Suppl","key":"9912_CR69","doi-asserted-by":"publisher","first-page":"S2","DOI":"10.1016\/j.parkreldis.2007.06.007","volume":"13","author":"E Tolosa","year":"2007","unstructured":"Tolosa E, Compta Y, Gaig C (2007) The premotor phase of Parkinson\u2019s disease. Parkinsonism Relat Disord 13(Suppl):S2\u2013S7. \n                    https:\/\/doi.org\/10.1016\/j.parkreldis.2007.06.007","journal-title":"Parkinsonism Relat Disord"},{"key":"9912_CR70","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/0304-3940(94)90090-6","volume":"176","author":"M Unzeta","year":"1994","unstructured":"Unzeta M, Baron S, Perez V, Ambrosio S, Mahy N (1994) Sex-related effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydro-pyridine treatment may be related to differences in monoamine oxidase B. Neurosci Lett 176:235\u2013238. \n                    https:\/\/doi.org\/10.1016\/0304-3940(94)90090-6","journal-title":"Neurosci Lett"},{"key":"9912_CR71","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1159\/000087097","volume":"52","author":"P Willner","year":"2005","unstructured":"Willner P (2005) Chronic mild stress (CMS) revisited: consistency and behavioural-neurobiological concordance in the effects of CMS. Neuropsychobiology 52:90\u2013110. \n                    https:\/\/doi.org\/10.1159\/000087097","journal-title":"Neuropsychobiology"},{"key":"9912_CR72","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1159\/000479111","volume":"17","author":"JE Yoon","year":"2017","unstructured":"Yoon JE, Kim JS, Jang W, Park J, Oh E, Youn J, Park S, Cho JW (2017) Gender differences of nonmotor symptoms affecting quality of life in Parkinson disease. Neurodegener Dis 17:276\u2013280. \n                    https:\/\/doi.org\/10.1159\/000479111","journal-title":"Neurodegener Dis"}],"container-title":["Neurotoxicity Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12640-018-9912-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12640-018-9912-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12640-018-9912-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,27]],"date-time":"2019-05-27T19:05:05Z","timestamp":1558983905000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12640-018-9912-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,28]]},"references-count":72,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,11]]}},"alternative-id":["9912"],"URL":"https:\/\/doi.org\/10.1007\/s12640-018-9912-4","relation":{},"ISSN":["1029-8428","1476-3524"],"issn-type":[{"value":"1029-8428","type":"print"},{"value":"1476-3524","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,28]]},"assertion":[{"value":"25 October 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 April 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 May 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was developed in accordance with the recommendations of the Guide for the Care and Use of Laboratory Animals of the National Institute of Health and was approved by the Committee on Ethics of Animal Experiments of the Universidade Federal de Santa Catarina (protocol number 2895030817). All the efforts were made to minimize the number of animals used and their suffering.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}